The Covid-19 vaccine Comirnaty is being recommended for 12 to 15-year-olds
The European Medicines Agency (EMA) recommends that the COVID-19 vaccine Comirnaty, which is manufactured by the pharmaceutical company Pfizer-BioNTech, be approved for 12 to...
Changes related to entry into Sweden
The government has today presented a number of changes concerning entry into Sweden. The entry ban is extended for travel from outside the EU. The requirement for a negative...
Prolonged restrictions due to high rate of spread of infection
The Government and the Public Health Agency of Sweden are prolonging several restrictions in the country until 17 May. This is because the rate of spread of Covid-19 remains high...
New recommendations for vaccinated
Three weeks after the first dose, people who have been vaccinated may meet indoors with others from a few different households. They may also go shopping in store. Vaccinated...
Negative Covid-19 test result required for entry into Sweden
As of Saturday 6 February, foreign nationals will need to present a negative Covid-19 test result in order to travel into Sweden.
Signs of increased spread of British virus variant
The Public Health Agency of Sweden has investigated more than 2000 cases of Covid-19 to detect the presence of the British mutated virus variant in Sweden. Eleven per cent of the...
Weather warning concerning snow and storm in parts of Northern Sweden
The Swedish Meteorological and Hydrological Institute has issued weather warnings for heavy drifting snow and storms in parts of northern Sweden.
Travellers from Brazil urged to get tested and avoid contact with others
The Public Health Agency of Sweden recommends that people who have been to Brazil and travelled into Sweden get tested for Covid-19 and avoid contact with others.
Extension of several Covid-19 restrictions
The government announces that the following restrictions will be extended because of the spread of Covid-19.
Moderna vaccine covered by pharmaceutical insurance scheme
A new agreement has been signed that means the state will bear the cost of any adverse effects of the Moderna COVID-19 vaccine.